• Study of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications

    Recruiting

    3 1
    Investigated diseases:
    Bulgaria Croatia Czechia France Germany Hungary +3
  • Study of psilocybin compared to personalized rTMS treatment in adults with treatment-resistant depression

    Recruiting

    2 1
    Investigated diseases:
    Italy
  • Long-term safety and effectiveness study of APG777 injection in patients with moderate-to-severe atopic dermatitis who previously received APG777 treatment

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Hungary Poland Spain
  • Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

    Recruiting

    3 1 1 1
    Investigated diseases:
    Norway
  • Study of BMS-986504 for patients with advanced or metastatic non-small cell lung cancer with homozygous MTAP deletion who have previously received treatment

    Recruiting

    2 1 1
    Investigated diseases:
    France Germany Italy Poland Romania Spain +1
  • Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Croatia Czechia Denmark Estonia +10
  • Study of momelotinib in patients with VEXAS syndrome and myelodysplastic syndrome who are dependent on or do not respond to steroid treatment

    Recruiting

    2 1 1
    Investigated diseases:
    France
  • Comparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Hungary Latvia Lithuania Poland
  • Study of MK-5684 compared to standard therapy in patients with breast cancer, ovarian cancer, or endometrial cancer

    Recruiting

    4 1 1 1
    Spain
  • Study of ONO-4578 and nivolumab with drug combination for first-line treatment in patients with PD-L1 positive advanced colorectal cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    France Italy Spain

powered by